Ken Griffin Bausch & Lomb Corp Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$14.59 - $20.0 $414,356 - $568,000	28,400 Added 36.46%	106,300 $2.05 Million
Q2 2024 Aug 14, 2024	BUY	$13.6 - $17.06 $183,600 - $230,309	13,500 Added 20.96%	77,900 $1.13 Million
Q1 2024 May 15, 2024	BUY	$13.68 - $17.6 $495,216 - $637,120	36,200 Added 128.37%	64,400 $1.11 Million
Q4 2023 Feb 14, 2024	BUY	$14.87 - $17.56 $251,303 - $296,764	16,900 Added 149.56%	28,200 $481,000
Q3 2023 Nov 14, 2023	SELL	$16.8 - $20.99 $851,760 - $1.06 Million	-50,700 Reduced 81.77%	11,300 $191,000
Q2 2023 Aug 14, 2023	BUY	$16.03 - $20.07 $17,633 - $22,077	1,100 Added 1.81%	62,000 $1.24 Million
Q1 2023 May 15, 2023	BUY	$15.67 - $18.91 $879,087 - $1.06 Million	56,100 Added 1168.75%	60,900 $1.06 Million
Q4 2022 Feb 14, 2023	SELL	$13.5 - $17.14 $986,850 - $1.25 Million	-73,100 Reduced 93.84%	4,800 $74,000
Q3 2022 Nov 14, 2022	BUY	$14.23 - $17.76 $190,682 - $237,984	13,400 Added 20.78%	77,900 $1.2 Million

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.25B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.